RankingsPricing
  1. US-listed companies
  2. REPLIGEN CORP
  3. Financials
  4. Diluted EPS

REPLIGEN CORPRGEN

Market cap
$9.1B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 2024-0.5-162.16%
Dec 31, 20230.7-77.16%
Dec 31, 20223.2+44.64%
Dec 31, 20212.2+101.80%
Dec 31, 20201.1+152.27%
Dec 31, 20190.4+18.92%
Dec 31, 20180.4-48.61%
Dec 31, 20170.7+111.76%
Dec 31, 20160.3+21.43%
Dec 31, 20150.3+12.00%
Dec 31, 20140.3-50.00%
Dec 31, 20130.5+11.11%
Dec 31, 20120.5-1000.00%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)